Triac Trial II in MCT8 Deficiency Patients
Triac Trial II in MCT8 Deficiency Patients
Active, not recruiting · NCT02396459 · Registry updated 2026-02-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Triac Trial II in MCT8 Deficiency Patients | Allan-Herndon-Dudley syndrome | Active, not recruiting | Phase 2 | 2026-02-20 | NCT02396459 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Erasmus Medical Center | 271 |
| Rare Thyroid Therapeutics International AB | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Charité - Universitätsmedizin Berlin Institut fur experimental paediatrische endokrinologie | Berlin | Germany | 1 |
| Charles University and Motol University Hospital; The department of peadiatrics of the 2nd faculty of medicine | Prague | Czechia | 1 |
| Children's Hospital of Philadelphia | Philadelphia | United States | 434 |
| Erasmus MC | Rotterdam | Netherlands | 44 |
| Oregon Health & Science University (OHSU) Doernbecher Childrens Hospital | Portland | United States | 1 |